在克里斯蒂治疗的癌症患者的并发症
Azadeh Abravan1,2, Corinne Faivre-Finn3,4, Fabio Gomes4
1Division of Cancer Sciences, The University of Manchester, Manchester, United Kingdom. azadeh.abravan@manchester.ac.uk.
British journal of cancer
|September 4, 2024
概括
伴随性疾病在癌症患者中很常见,在诊断时几乎影响了60%的患者. 肺癌显示出最高的并发病率,而心血管问题是最常见的整体.
科学领域:
- 在瘤学瘤学.
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 伴随性疾病显著影响癌症患者的表现和治疗结果.
- 了解并发症模式对于全面的癌症护理至关重要.
研究的目的:
- 在一个大规模的泛癌患者队列中调查并发症的患病率和模式.
- 分析并发症负担与人口统计学/社会经济因素之间的关系.
主要方法:
- 对77,149名癌症患者的回顾性审查 (2014年1月1日~2022年12月15日).
- 在12个器官系统中使用了成人并发症评估27 (ACE-27) 评分.
- 使用后勤回归来评估并发症发病率因素.
主要成果:
- 59.7%的患者在诊断时至少有一种并发症.
- 肺癌患病率最高;脑/中枢神经系统和内分泌癌症患病率最低.
- 心血管并发症是最常见的;严重程度与剥夺,年龄和表现状况有关.
结论:
- 伴随性疾病在各种癌症类型中非常普遍.
- 某些患者群体表现出更高的并发病率.
- 进一步的研究对于阐明伴随性疾病对癌症管理的影响至关重要.
相关概念视频
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

